• About us 


Aim: Focusing on the feature of genetic data, such as privacy, evolution, multi-measure, heterogeneity, systematicness, and so on, combing molecular biology experiments and clinical scientific issues contribute to the reestablishment of dynamic evolving molecular networks of disease, the scientific basis and informatics platform for the precise diagnosis, treatment and intelligent health management of diseases. Thus, our specific work follow the three aspects:

  1. Establishing the model and platform for disease biomedical data sharing and security, such as the disease-specific ontology; the ontology-based data sharing model and the data security protection,  database and knowledge base for a series of disease, etc;
  2. Establishing different omits, such as genomics, proteomics, metabonomics, microbiome, single-cell omics, physiological phenotypes, and clinical phenotypes, cheminformatics, etc,  unique ecological network models and data analysis platforms of various omits;
  3. Establishing knowledge-guided biomedical and health intelligence engineering, and promoting the transformation and application of informatics in chronic disease management, hierarchical diagnosis and treatment, and personalized health management.

• Publication 


Zhang C, Singla RK, Tang M, Shen B. Natural products act as game-changer potentially in treatment and management of sepsis-mediated inflammation: A clinical perspective. Phytomedicine. 2024 May 3;130:155710. doi: 10.1016/j.phymed.2024.155710. Epub ahead of print. PMID: 38759311.

Ullah A, Chen Y, Singla RK, Cao D, Shen B. Pro-inflammatory Cytokines and CXC Chemokines as Game-Changer in Age-Associated Prostate Cancer and Ovarian Cancer: Insights from Preclinical and Clinical Studies' Outcomes. Pharmacol Res. 2024 May 13:107213. doi: 10.1016/j.phrs.2024.107213. Epub ahead of print. PMID: 38750677.

Ullah A, Jiao W, Shen B. The role of proinflammatory cytokines and CXC chemokines (CXCL1-CXCL16) in the progression of prostate cancer: insights on their therapeutic management. Cell Mol Biol Lett. 2024 May 14;29(1):73. doi: 10.1186/s11658-024-00591-9. PMID: 38745115; PMCID: PMC11094955.

Ullah A, Singla RK, Batool Z, Cao D, Shen B. Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases). Rev Endocr Metab Disord. 2024 May 6. doi: 10.1007/s11154-024-09884-y. Epub ahead of print. PMID: 38709387.

Zheng M, Kumar A, Sharma V, Behl T, Sehgal A, Wal P, Shinde NV, Kawaduji BS, Kapoor A, Anwer MK, Gulati M, Shen B, Singla RK, Bungau SG. Revolutionizing pediatric neuroblastoma treatment: unraveling new molecular targets for precision interventions. Front Cell Dev Biol. 2024 Mar 27;12:1353860. doi: 10.3389/fcell.2024.1353860. PMID: 38601081; PMCID: PMC11004261.